Applied BioCode Corporation (TPE:6598)
Taiwan · Delayed Price · Currency is TWD 24.50
+0.30 (1.24%)
At close: Mar 5, 2026
Applied BioCode Revenue
Applied BioCode had revenue of 122.82M TWD in the quarter ending September 30, 2025, with 63.87% growth. This brings the company's revenue in the last twelve months to 443.69M, up 14.85% year-over-year. In the year 2024, Applied BioCode had annual revenue of 343.07M, down -13.18%.
Revenue (ttm)
443.69M
Revenue Growth
+14.85%
P/S Ratio
5.68
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 343.07M | -52.10M | -13.18% |
| Dec 31, 2023 | 395.17M | 4.87M | 1.25% |
| Dec 31, 2022 | 390.30M | 70.34M | 21.98% |
| Dec 31, 2021 | 319.96M | 20.95M | 7.01% |
| Dec 31, 2020 | 299.02M | 194.32M | 185.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.80B |
| Cowealth Medical Holding | 3.41B |
| Wellell | 2.39B |
| OK Biotech | 1.64B |
| Dynamic Medical Technologies | 1.43B |
| WeLeader Biomedical | 1.06B |
| A Plus Biotechnology | 825.52M |
| Diamond Biotechnology | 698.11M |